Literature DB >> 291466

Chromosomes and causation of human cancer and leukemia. XXXIV. A case of "hypereosinophilic syndrome" with unusual cytogenetic findings in a chloroma, terminating in blastic transformation and CNS leukemia.

C S Huang, G A Gomez, S I Kohno, J E Sokal, A A Sandberg.   

Abstract

A 47-year-old white male developed massive hepatosplenomegaly, a pleural effusion, leucocytosis, and a left parasternal mass following a relatively symptom-free persistent hypereosinophilia for about 5 years. Bone marrow aspiration and biopsy and peripheral blood differential showed eosinophilia and a shift to the left with immature cells. A high serum B12 vitamin level and low LAP activity were found. Biopsy of the soft tissue mass revealed a granulocytic sarcoma (chloroma) with a hyperdiploid karyotype (49,XY, + 10, + 15, + 19,3q-), whereas the bone marrow cells had a normal male karyotype. The patient responded temporarily to chemotherapy but eventually developed CNS leukemia and went on to terminate in a frank blastic phase. This case illustrates hypereosinophilia and a myeloproliferative syndrome characterized by a somewhat indolent chronic course evolving into "eosinophilic leukemia" and granulocytic sarcoma, CNS involvement by leukemic cells and, finally, blastic transformation. It is possible that this case represents a variant of Ph1-negative CML to which the term "chronic eosinophilic leukemia" could be justifiably applied.

Entities:  

Mesh:

Year:  1979        PMID: 291466     DOI: 10.1002/1097-0142(197910)44:4<1284::aid-cncr2820440418>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Hypereosinophilia in a patient with acute lymphoblastic leukemia.

Authors:  Y Merrick; L P Rasmussen; C Geisler; B V Jensen; B Guldhammer
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

2.  Eosinophilic leukaemia with trisomy 8 and double gammopathy.

Authors:  I Ribeiro; I R Carvalho; M Fontes; F Lima; R Matos; B A Anderson; L S Uva
Journal:  J Clin Pathol       Date:  1993-07       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.